Concepedia

Shuanglan Xu

SX

Statistics

Publications

11

Citations

203

H-Index

10

Active since

2019

Affiliations

First Affiliated Hospital of Kunming Medical University(Current)

Kunming Medical University

Second People's Hospital of Yunnan Province

Nanjing Medical University

Yunnan University

Shuanglan Xu is an author at First Affiliated Hospital of Kunming Medical University specializing in life sciences, pulmonary hypertension, and molecular biology.

ORCID

Publications per year

2019–2024

11

Publications

11

5-Aza-2′-deoxycytidine, a DNA methylation inhibitor, attenuates hypoxic pulmonary hypertension via demethylation of the PTEN promoter

Xiqian Xing, Bo Li, Shuanglan Xu et al. · European Journal of Pharmacology · 2019 · 35 citations

, , +15

PDGF mediates pulmonary arterial smooth muscle cell proliferation and migration by regulating NFATc2

Fangyun Zhao, Shuanglan Xu, Chunfang Zhang et al. · Molecular Medicine Reports · 2020 · 35 citations · Full text

, , +7

MicroRNA-214-3p Regulates Hypoxia-Mediated Pulmonary Artery Smooth Muscle Cell Proliferation and Migration by Targeting ARHGEF12

Xiqian Xing, Bo Li, Shuanglan Xu et al. · Medical Science Monitor · 2019 · 22 citations · Full text

, , +13

Regulation of circular RNAs act as ceRNA in a hypoxic pulmonary hypertension rat model

Shuanglan Xu, Yishu Deng, Jie Liu et al. · Genomics · 2020 · 20 citations

, , +14

Animal models: An essential tool to dissect the heterogeneity of chronic obstructive pulmonary disease

Jingxian Jiang, Shuanglan Xu, Zi Chen et al. · Journal of Translational Internal Medicine · 2023 · 20 citations · Full text

, , +11

1–5 of 11